10 hours Ago By ABMN Staff
Tempus AI ( NASDAQ:TEM – Get Free Report ) will likely be posting its quarterly earnings results after the market closes on Monday, February 24th. Analysts expect Tempus AI to post earnings of ($0.15) per share and revenue of $202.
80 million for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link . Tempus AI Stock Performance Shares of NASDAQ:TEM opened at $68.
09 on Friday. The stock has a fifty day simple moving average of $50.29 and a two-hundred day simple moving average of $51.
65. Tempus AI has a 12-month low of $22.89 and a 12-month high of $91.
45. The company has a current ratio of 2.69, a quick ratio of 2.
55 and a debt-to-equity ratio of 8.17. Insider Transactions at Tempus AI In related news, Director David R.
Epstein sold 620 shares of Tempus AI stock in a transaction on Wednesday, December 11th. The stock was sold at an average price of $41.81, for a total value of $25,922.
20. Following the completion of the sale, the director now owns 27,894 shares of the company’s stock, valued at $1,166,248.14.
The trade was a 2.17 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link .
Also, CEO Eric P. Lefkofsky sold 84,640 shares of Tempus AI stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $80.
87, for a total value of $6,844,836.80. Following the completion of the sale, the chief executive officer now directly owns 4,964,820 shares of the company’s stock, valued at $401,504,993.
40. The trade was a 1.68 % decrease in their position.
The disclosure for this sale can be found here . Insiders sold 2,583,467 shares of company stock worth $130,542,311 over the last quarter. Wall Street Analyst Weigh In Get Our Latest Stock Analysis on TEM Tempus AI Company Profile ( Get Free Report ) Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare.
The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Read More Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter .
.
